Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Autolus Therapeutics (AUTL) Operating Margin (2022 - 2025)

Autolus Therapeutics (AUTL) has disclosed Operating Margin for 3 consecutive years, with 337.93% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Margin changed N/A year-over-year to 337.93%, compared with a TTM value of 535.89% through Sep 2025, up 163077.0%, and an annual FY2024 reading of 2385.63%, up 819747.0% over the prior year.
  • Operating Margin was 337.93% for Q3 2025 at Autolus Therapeutics, down from 292.58% in the prior quarter.
  • Across five years, Operating Margin topped out at 292.58% in Q2 2025 and bottomed at 379320.0% in Q4 2024.
  • Average Operating Margin over 3 years is 56379.76%, with a median of 726.34% recorded in 2025.
  • The sharpest move saw Operating Margin surged 264630bps in 2024, then plummeted -34261bps in 2025.
  • Year by year, Operating Margin stood at 10567.73% in 2023, then plummeted by -3489bps to 379320.0% in 2024, then surged by 100bps to 337.93% in 2025.
  • Business Quant data shows Operating Margin for AUTL at 337.93% in Q3 2025, 292.58% in Q2 2025, and 726.34% in Q1 2025.